Pathobiont immune tuning: the untold consequences of Staphylococcus aureus exposure on host immunity.

Trends Microbiol

Host-Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland. Electronic address:

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Staphylococcus aureus is a formidable pathogen and major challenge to human health. However, the bacterium is dichotomous and also acts as an asymptomatic coloniser. Given its ubiquity, every individual has been exposed to the bacterium, which may 'tune' the host immune system. This prior exposure potentially hampers the efficacy of anti-S. aureus vaccines, diminishing their protective effect. Conversely, by preserving its niche as a commensal coloniser, the bacterium simultaneously contributes to host defence through interbacterial competition and stimulation of host immune responses, potentially fending off pathogenic threats. This review examines how S. aureus shapes host immunity via infection and colonisation and explores how S. aureus-associated immune tuning can be both problematic and beneficial for the host.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tim.2025.07.008DOI Listing

Publication Analysis

Top Keywords

immune tuning
8
staphylococcus aureus
8
host immunity
8
host immune
8
host
6
pathobiont immune
4
tuning untold
4
untold consequences
4
consequences staphylococcus
4
aureus
4

Similar Publications

Immunostimulatory and Immunomodulatory Effects of Vitamin B12 Derivatives on Macrophages Through the Modulation of JNK Pathway.

Cell Biochem Biophys

September 2025

Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul, 34003, Türkiye, Turkey.

Vitamin B12 is a vital water-soluble vitamin containing a central cobalt atom within its corrin ring structure. It exists in several derivatives, among which methylcobalamin (MeCbl) and adenosylcobalamin (AdCbl) are the biologically active forms that serve as cofactors in essential enzymatic reactions. Although the neurological and hematological consequences of vitamin B12 deficiency have been extensively studied, its role in immune regulation remains less well understood.

View Article and Find Full Text PDF

Zika virus (ZIKV) is a mosquito-borne flavivirus causing a major epidemic in the Americas in 2015. Dendritic cells (DCs) are leukocytes with key antiviral functions, but their role in ZIKV infection remains under investigation. While most studies have focused on the monocyte-derived subtype of DCs, less is known about conventional dendritic cells (cDCs), essential for the orchestration of antiviral adaptive immunity.

View Article and Find Full Text PDF

Novel immunopotentiators are essential for advancing our understanding of immune receptor crosstalk and for addressing infectious diseases. Previous studies have suggested that coactivation of nucleotide-binding oligomerization domain-containing protein 2 (NOD2) and Toll-like receptor 4 (TLR4) can synergistically enhance the immune response. To investigate this synergy, we synthesized and evaluated a series of conjugated NOD2/TLR4 dual agonists comprising our in-house NOD2 agonist and two structurally distinct TLR4 agonists connected via flexible or rigid linkers.

View Article and Find Full Text PDF

Blood, which forms part of the systemic circulatory system, contains proteins from various tissues and organs. Hence, blood samples are ideal vehicles for studying diseases and physiological states. Plasma is an important component of blood and is essential for clinical proteomics research.

View Article and Find Full Text PDF

Adoptive Cell Therapy (ACT) has achieved curative responses in hematological malignancies, yet its translation to solid tumors remains limited by manufacturing bottlenecks, systemic toxicities, and poor T-cell infiltration and persistence within the immunosuppressive tumor microenvironment (TME). Here, we report the development and mechanism of ACTIVATE (Adoptive Cell Therapy and Immunostimulatory Vehicle for Anti-Tumor Efficacy), which leverages an injectable hydrogel depot technology that forms a transient inflammatory niche for localized co-delivery of adoptive T cells and native cytokines. By tuning cytokine identity, ACTIVATE enables precise modulation of T-cell expansion, effector function, and interaction with endogenous immune networks.

View Article and Find Full Text PDF